Apr 30, 2021 / 12:00PM GMT
Operator
Ladies and gentlemen, good day and welcome to the Ajanta Pharma Q4FY21 conference call. I would like to hand the conference over to Mr. Yogesh Agrawal, Managing Director of Ajanta Pharma Limited. Thank you and over to you sir.
Yogesh Agrawal - Ajanta Pharma Ltd. - MD
Thank you. Good evening and welcome to all of you. With me, I have Mr. Rajesh Agrawal, our Joint Managing Director, and Mr. Arvind Agrawal, our CFO. We sincerely hope that all of you are safe and healthy and taking abundant precaution against the second wave of the pandemic. Financial year 2021 saw the full impact of COVID-19 on life and business, we could have never imagined.
As we remain persistent to grow, we quickly adapted to new normal for working and ensure that we service all our customers globally without any interruption or shortages in the supply. This has enabled us to achieve once again, a remarkable performance in a very difficult year.
Coming to the results, we are already with you now, and I'm happy to share that this has been an exciting quarter and the financial
Q4 2021 Ajanta Pharma Ltd Earnings Call Transcript
Apr 30, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers